Technical Analysis for ACUR - Acura Pharmaceuticals, Inc.

Grade Last Price % Change $ Change
grade D $0.78 -9.29% -0.08
ACUR closed down 9.29 percent on Tuesday, February 21, 2017, on 24 percent of normal volume. It was able to find support at its 50 day moving average.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical ACUR trend table...

Date Alert Name Type % Chg
Feb 21 50 DMA Support Bullish 0.00%
Feb 21 Narrow Range Bar Range Contraction 0.00%
Feb 21 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Feb 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Feb 17 50 DMA Support Bullish -9.30%
Feb 17 Hammer Candlestick Bullish -9.30%
Feb 17 1,2,3 Pullback Bullish Bullish Swing Setup -9.30%
Feb 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -9.30%
Feb 16 50 DMA Support Bullish -12.36%
Feb 16 1,2,3 Pullback Bullish Bullish Swing Setup -12.36%

Older signals for ACUR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Profile
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies. Its products include Oxecta Tablets CII, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed, an over-the-counter immediate-release pseudoephedrine HCl tablet that is used as a nasal decongestant in various non-prescription and prescription cold, sinus, and allergy products. The company has seven additional opioid products utilizing Aversion technology in various stages of development. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc., a wholly-owned subsidiary of Pfizer Inc. to develop and commercialize certain opioid analgesic products utilizing the company’s proprietary Aversion technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.
Is ACUR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.52
52 Week Low 0.5
Average Volume 677,058
200-Day Moving Average 1.46
50-Day Moving Average 0.77
20-Day Moving Average 0.79
10-Day Moving Average 1.03
Average True Range 0.2
ADX 47.56
+DI 27.56
-DI: 17.32
Chandelier Exit (Long, 3 ATRs) 0.8
Chandelier Exit (Short, 3 ATRs) 1.1
Upper Bollinger Band 1.33
Lower Bollinger Band 0.25
Percent B (%b) 0.49
Bandwidth 1.367089